Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities

Melanoma is the deadliest form of skin cancer and remains a diagnostic challenge in the dermatology clinic. Several non-invasive imaging techniques have been developed to identify melanoma. The signal source in each of these modalities is based on the alteration of physical characteristics of the ti...

Full description

Bibliographic Details
Main Authors: Monica Hessler, Elmira Jalilian, Qiuyun Xu, Shriya Reddy, Luke Horton, Kenneth Elkin, Rayyan Manwar, Maria Tsoukas, Darius Mehregan, Kamran Avanaki
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/24/9583
_version_ 1797544523568513024
author Monica Hessler
Elmira Jalilian
Qiuyun Xu
Shriya Reddy
Luke Horton
Kenneth Elkin
Rayyan Manwar
Maria Tsoukas
Darius Mehregan
Kamran Avanaki
author_facet Monica Hessler
Elmira Jalilian
Qiuyun Xu
Shriya Reddy
Luke Horton
Kenneth Elkin
Rayyan Manwar
Maria Tsoukas
Darius Mehregan
Kamran Avanaki
author_sort Monica Hessler
collection DOAJ
description Melanoma is the deadliest form of skin cancer and remains a diagnostic challenge in the dermatology clinic. Several non-invasive imaging techniques have been developed to identify melanoma. The signal source in each of these modalities is based on the alteration of physical characteristics of the tissue from healthy/benign to melanoma. However, as these characteristics are not always sufficiently specific, the current imaging techniques are not adequate for use in the clinical setting. A more robust way of melanoma diagnosis is to “stain” or selectively target the suspect tissue with a melanoma biomarker attached to a contrast enhancer of one imaging modality. Here, we categorize and review known melanoma diagnostic biomarkers with the goal of guiding skin imaging experts to design an appropriate diagnostic tool for differentiating between melanoma and benign lesions with a high specificity and sensitivity.
first_indexed 2024-03-10T14:01:45Z
format Article
id doaj.art-1d9dc9c58bba43f48f9ff45cb50bbcca
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T14:01:45Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-1d9dc9c58bba43f48f9ff45cb50bbcca2023-11-21T01:01:33ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-12-012124958310.3390/ijms21249583Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging ModalitiesMonica Hessler0Elmira Jalilian1Qiuyun Xu2Shriya Reddy3Luke Horton4Kenneth Elkin5Rayyan Manwar6Maria Tsoukas7Darius Mehregan8Kamran Avanaki9Department of Biomedical Engineering, Wayne State University, Detroit, MI 48201, USADepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60607, USADepartment of Biomedical Engineering, Wayne State University, Detroit, MI 48201, USADepartment of Biomedical Engineering, Wayne State University, Detroit, MI 48201, USADepartment of Biomedical Engineering, Wayne State University, Detroit, MI 48201, USADepartment of Biomedical Engineering, Wayne State University, Detroit, MI 48201, USADepartment of Biomedical Engineering, Wayne State University, Detroit, MI 48201, USADepartment of Dermatology, University of Illinois at Chicago, Chicago, IL 60607, USADepartment of Dermatology, School of Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USARichard and Loan Hill Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60607, USAMelanoma is the deadliest form of skin cancer and remains a diagnostic challenge in the dermatology clinic. Several non-invasive imaging techniques have been developed to identify melanoma. The signal source in each of these modalities is based on the alteration of physical characteristics of the tissue from healthy/benign to melanoma. However, as these characteristics are not always sufficiently specific, the current imaging techniques are not adequate for use in the clinical setting. A more robust way of melanoma diagnosis is to “stain” or selectively target the suspect tissue with a melanoma biomarker attached to a contrast enhancer of one imaging modality. Here, we categorize and review known melanoma diagnostic biomarkers with the goal of guiding skin imaging experts to design an appropriate diagnostic tool for differentiating between melanoma and benign lesions with a high specificity and sensitivity.https://www.mdpi.com/1422-0067/21/24/9583melanomabiomarkersskin cancerbenign nevinon-invasive
spellingShingle Monica Hessler
Elmira Jalilian
Qiuyun Xu
Shriya Reddy
Luke Horton
Kenneth Elkin
Rayyan Manwar
Maria Tsoukas
Darius Mehregan
Kamran Avanaki
Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities
International Journal of Molecular Sciences
melanoma
biomarkers
skin cancer
benign nevi
non-invasive
title Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities
title_full Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities
title_fullStr Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities
title_full_unstemmed Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities
title_short Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities
title_sort melanoma biomarkers and their potential application for in vivo diagnostic imaging modalities
topic melanoma
biomarkers
skin cancer
benign nevi
non-invasive
url https://www.mdpi.com/1422-0067/21/24/9583
work_keys_str_mv AT monicahessler melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT elmirajalilian melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT qiuyunxu melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT shriyareddy melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT lukehorton melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT kennethelkin melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT rayyanmanwar melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT mariatsoukas melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT dariusmehregan melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities
AT kamranavanaki melanomabiomarkersandtheirpotentialapplicationforinvivodiagnosticimagingmodalities